Skip to main content
. Author manuscript; available in PMC: 2016 Oct 25.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2016 May 28;96(2):362–371. doi: 10.1016/j.ijrobp.2016.05.026

Table 4. Two-year endpoints by p16 status and neck treatment after chemoradiation.

2-y Estimates (%)

Parameter Patients (n) LRF PFS OS
p16 positive
 No neck dissection 130 11.2 (6.4-17.5) 75.3 (67.9-82.8) 86.9 (81.1-92.7)
 Neck dissection with pCR 54 7.5 (2.4-16.7) 85.2 (75.7-94.7) 92.6 (85.6-99.6)
 Neck dissection without pCR 15 20.0 (4.5-43.3) 73.3 (51.0-95.7) 86.7 (69.5-100.0)
 Neck dissection with/without pCR 69 10.2 (4.5-18.8) 82.6 (73.7-91.6) 91.3 (84.7-98.0)
p16 negative
 No neck dissection 63 31.1 (19.9-43.0) 47.6 (35.3-60.0) 57.1 (44.9-69.4)
 Neck dissection with pCR 16 26.0 (7.5-49.6) 50.0 (25.5-74.5) 62.5 (38.8-86.2)
 Neck dissection without pCR 14 75.0 (36.0-92.2) 14.3 (0.0-32.6) 50.0 (23.8-76.2)
 Neck dissection with/without pCR 30 49.1 (29.2-66.3) 33.3 (16.5-50.2) 56.7 (38.9-74.4)

Abbreviations as in Table 3.